Press Resease

Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, and Software & Services), by Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Enzyme Immunoassays, Radioimmunoassay, and Others), by Technology (ELISA, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Others), by Application (Infectious Disease, Endocrinology, Oncology, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, and Others), and by End-User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 21-Feb-2019 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-1768 Status : Published

Global immunoassay market expected to generate around USD 29.79 billion by 2025, at a CAGR of around 6.5% between 2019 and 2025. Immunoassay is a type of biochemistry technique that is used either qualitatively or quantitatively to detect the presence of analytes.

Description

The report covers a forecast and an analysis of the immunoassay market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the immunoassay market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immunoassay market on a global level.

In order to give the users of this report a comprehensive view of the immunoassay market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Immunoassay Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the immunoassay market by segmenting it based on product and service, platform, technology, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.

Some key players of the global immunoassay market are Siemens, Roche, Abbott Laboratories, Danaher Corporation, QIAGEN, Thermo Fischer Scientific, Bio-Rad Laboratories, Agilent Technologies, bioMerieux, Merck, Bio-Techne Corporation, and PerkinElmer.

This report segments the global immunoassay market into:

Global Immunoassay Market: Product and Service Analysis

  • Reagents and Kits
  • Analyzers
  • Software and Services
  • Global Immunoassay Market: Platform Analysis
  • Chemiluminescence Immunoassays (CLIAs)
  • Fluorescence Immunoassays (FIAs)
  • Enzyme Immunoassays (EIs)
  • Radioimmunoassays (RIAs)
  • Others

Global Immunoassay Market: Technology Analysis

  • ELISA
  • Rapid Tests
  • Western Blotting
  • ELISPOT
  • Immuno-PCR
  • Others

Global Immunoassay Market: Application Analysis

  • Infectious Disease
  • Endocrinology
  • Oncology
  • Cardiology
  • Hematology and Blood Screening
  • Autoimmune Disorders
  • Others

Global Immunoassay Market: End-User Analysis

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies 
  • Contract Research Organizations (CROs)
  • Blood Banks
  • Others

Global Immunoassay Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global immunoassay market, 2016-2025 (USD Billion)
    • 2.2. Global immunoassay market: Snapshot
  •  
  • Chapter 3. Immunoassay Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global immunoassay market drivers: Impact analysis
      • 3.2.2. Increasing Incidences of Chronic and Infectious Diseases
      • 3.2.3. Technological Advancements related to Immunoassay Instruments
      • 3.2.4. Growth of the Biotechnology and Biopharmaceutical Industries
      • 3.2.5. Vital Role of Immunoassays in Drug and Alcohol Testing
    • 3.3. Market Restraints
      • 3.3.1. Global immunoassay market restraints: Impact analysis
      • 3.3.2. Stringent Regulatory Requirements for the Approval of Immunoassay Instruments and Consumables
      • 3.3.3. Unfavorable Reimbursement Scenario
    • 3.4. Opportunities
      • 3.4.1. Increasing Importance of Companion Diagnostics
      • 3.4.2. Development of Condition-Specific Biomarkers and Tests
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product and service
      • 3.6.2. Market attractiveness analysis, by platform
      • 3.6.3. Market attractiveness analysis, by technology
      • 3.6.4. Market attractiveness analysis, by application
      • 3.6.5. Market attractiveness analysis, by end-user
      • 3.6.6. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Immunoassay Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global immunoassay market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New platform launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Immunoassay Market - Product & Service Analysis
    • 5.1. Global immunoassay market: Product & Service overview
      • 5.1.1. Global immunoassay market revenue share, by product & service, 2018 and 2025
    • 5.2. Reagents & Kits
      • 5.2.1. Global immunoassay market for reagents & kits, 2016-2025 (USD Billion)
    • 5.3. Analyzers
      • 5.3.1. Global immunoassay market for analyzers, 2016-2025 (USD Billion)
    • 5.4. Software & Services
      • 5.4.1. Global immunoassay market for software & services, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Immunoassay Market - Platform Analysis
    • 6.1. Global immunoassay market: Platform overview
      • 6.1.1. Global immunoassay market revenue share, by platform, 2018 and 2025
    • 6.2. Chemiluminescence Immunoassays (CLIAs)
      • 6.2.1. Global immunoassay market for CLIAs, 2016-2025 (USD Billion)
    • 6.3. Fluorescence Immunoassays (FIAs)
      • 6.3.1. Global immunoassay market for FIAs, 2016-2025 (USD Billion)
    • 6.4. Enzyme Immunoassays (EIs)
      • 6.4.1. Global immunoassay market for EIs, 2016-2025 (USD Billion)
    • 6.5. Radioimmunoassays (RIAs)
      • 6.5.1. Global immunoassay market for RIAs, 2016-2025 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global immunoassay market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Immunoassay Market - Technology Analysis
    • 7.1. Global immunoassay market: Technology overview
      • 7.1.1. Global immunoassay market revenue share, by technology, 2018 and 2025
    • 7.2. ELISA
      • 7.2.1. Global immunoassay market for ELISA, 2016-2025 (USD Billion)
    • 7.3. Rapid Tests
      • 7.3.1. Global immunoassay market for rapid tests, 2016-2025 (USD Billion)
    • 7.4. Western Blotting
      • 7.4.1. Global immunoassay market for western blotting, 2016-2025 (USD Billion)
    • 7.5. ELISPOT
      • 7.5.1. Global immunoassay market for ELISPOT, 2016-2025 (USD Billion)
    • 7.6. Immuno-PCR
      • 7.6.1. Global immunoassay market for immuno-PCR, 2016-2025 (USD Billion)
    • 7.7. Others
      • 7.7.1. Global immunoassay market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Immunoassay Market - Application Analysis
    • 8.1. Global immunoassay market: Application overview
      • 8.1.1. Global immunoassay market revenue share, by application, 2018 and 2025
    • 8.2. Infectious Disease
      • 8.2.1. Global immunoassay market for infectious disease, 2016-2025 (USD Billion)
    • 8.3. Endocrinology
      • 8.3.1. Global immunoassay market for endocrinology, 2016-2025 (USD Billion)
    • 8.4. Oncology
      • 8.4.1. Global immunoassay market for oncology, 2016-2025 (USD Billion)
    • 8.5. Cardiology
      • 8.5.1. Global immunoassay market for cardiology, 2016-2025 (USD Billion)
    • 8.6. Hematology & Blood Screening
      • 8.6.1. Global immunoassay market for hematology and blood screening, 2016-2025 (USD Billion)
    • 8.7. Autoimmune Disorders
      • 8.7.1. Global immunoassay market for autoimmune disorders, 2016-2025 (USD Billion)
    • 8.8. Others
      • 8.8.1. Global immunoassay market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Global Immunoassay Market - End-user Analysis
    • 9.1. Global immunoassay market: End-user overview
      • 9.1.1. Global immunoassay market revenue share, by End-user, 2018 and 2025
    • 9.2. Hospitals
      • 9.2.1. Global immunoassay market for hospitals, 2016-2025 (USD Billion)
    • 9.3. Clinical Laboratories
      • 9.3.1. Global immunoassay market for clinical laboratories, 2016-2025 (USD Billion)
    • 9.4. Pharmaceutical and Biotechnology Companies
      • 9.4.1. Global immunoassay market for pharmaceutical and biotechnology companies, 2016-2025 (USD Billion)
    • 9.5. Contract Research Organization (CROs)
      • 9.5.1. Global immunoassay market for CROs, 2016-2025 (USD Billion)
    • 9.6. Others
      • 9.6.1. Global immunoassay market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 10. Global Immunoassay Market- Regional Segment Analysis
    • 10.1. Global immunoassay market: Regional overview
      • 10.1.1. Global immunoassay market revenue share, by region, 2018 and 2025
    • 10.2. North America
      • 10.2.1. North America immunoassay market, 2016-2025 (USD Billion)
      • 10.2.2. North America immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
      • 10.2.3. North America immunoassay market revenue, by platform, 2016-2025 (USD Billion)
      • 10.2.4. North America immunoassay market revenue, by technology, 2016-2025 (USD Billion)
      • 10.2.5. North America immunoassay market revenue, by application, 2016-2025 (USD Billion)
      • 10.2.6. North America immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.2.7. The U.S.
        • 10.2.7.1. The U.S. immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.2.7.2. The U.S. immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.2.7.3. The U.S. immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.2.7.4. The U.S. immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.2.7.5. The U.S. immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.2.8. Canada
        • 10.2.8.1. Canada immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.2.8.2. Canada immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.2.8.3. Canada immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.2.8.4. Canada immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.2.8.5. Canada immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
    • 10.3. Europe
      • 10.3.1. Europe immunoassay market, 2016-2025 (USD Billion)
      • 10.3.2. Europe immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
      • 10.3.3. Europe immunoassay market revenue, by platform, 2016-2025 (USD Billion)
      • 10.3.4. Europe immunoassay market revenue, by technology, 2016-2025 (USD Billion)
      • 10.3.5. Europe immunoassay market revenue, by application, 2016-2025 (USD Billion)
      • 10.3.6. Europe immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.3.7. UK
        • 10.3.7.1. UK immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.3.7.2. UK immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.3.7.3. UK immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.3.7.4. UK immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.3.7.5. UK immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.3.8. Germany
        • 10.3.8.1. Germany immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.3.8.2. Germany immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.3.8.3. Germany immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.3.8.4. Germany immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.3.8.5. Germany immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.3.9. France
        • 10.3.9.1. France immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.3.9.2. France immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.3.9.3. France immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.3.9.4. France immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.3.9.5. France immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.3.10. Rest of Europe
        • 10.3.10.1. Rest of Europe immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.3.10.2. Rest of Europe immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.3.10.3. Rest of Europe immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.3.10.4. Rest of Europe immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.3.10.5. Rest of Europe immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific immunoassay market, 2016-2025 (USD Billion)
      • 10.4.2. Asia Pacific immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
      • 10.4.3. Asia Pacific immunoassay market revenue, by platform, 2016-2025 (USD Billion)
      • 10.4.4. Asia Pacific immunoassay market revenue, by technology, 2016-2025 (USD Billion)
      • 10.4.5. Asia Pacific immunoassay market revenue, by application, 2016-2025 (USD Billion)
      • 10.4.6. Asia Pacific immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.4.7. China
        • 10.4.7.1. China immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.4.7.2. China immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.4.7.3. China immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.4.7.4. China immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.4.7.5. China immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.4.8. Japan
        • 10.4.8.1. Japan immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.4.8.2. Japan immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.4.8.3. Japan immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.4.8.4. Japan immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.4.8.5. Japan immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.4.9. India
        • 10.4.9.1. India immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.4.9.2. India immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.4.9.3. India immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.4.9.4. India immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.4.9.5. India immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.4.10. Rest of Asia Pacific
        • 10.4.10.1. Rest of Asia Pacific immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.4.10.2. Rest of Asia Pacific immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.4.10.3. Rest of Asia Pacific immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.4.10.4. Rest of Asia Pacific immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.4.10.5. Rest of Asia Pacific immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
    • 10.5. Latin America
      • 10.5.1. Latin America immunoassay market, 2016-2025 (USD Billion)
      • 10.5.2. Latin America immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
      • 10.5.3. Latin America immunoassay market revenue, by platform, 2016-2025 (USD Billion)
      • 10.5.4. Latin America immunoassay market revenue, by technology, 2016-2025 (USD Billion)
      • 10.5.5. Latin America immunoassay market revenue, by application, 2016-2025 (USD Billion)
      • 10.5.6. Latin America immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.5.7. Brazil
        • 10.5.7.1. Brazil immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.5.7.2. Brazil immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.5.7.3. Brazil immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.5.7.4. Brazil immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.5.7.5. Brazil immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
      • 10.5.8. Rest of Latin America
        • 10.5.8.1. Rest of Latin America immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
        • 10.5.8.2. Rest of Latin America immunoassay market revenue, by platform, 2016-2025 (USD Billion)
        • 10.5.8.3. Rest of Latin America immunoassay market revenue, by technology, 2016-2025 (USD Billion)
        • 10.5.8.4. Rest of Latin America immunoassay market revenue, by application, 2016-2025 (USD Billion)
        • 10.5.8.5. Rest of Latin America immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
    • 10.6. The Middle East and Africa
      • 10.6.1. The Middle East and Africa immunoassay market, 2016-2025 (USD Billion)
      • 10.6.2. The Middle East and Africa immunoassay market revenue, by product & service, 2016-2025 (USD Billion)
      • 10.6.3. The Middle East and Africa immunoassay market revenue, by platform, 2016-2025 (USD Billion)
      • 10.6.4. The Middle East and Africa immunoassay market revenue, by technology, 2016-2025 (USD Billion)
      • 10.6.5. The Middle East and Africa immunoassay market revenue, by application, 2016-2025 (USD Billion)
      • 10.6.6. The Middle East and Africa immunoassay market revenue, by End-user, 2016-2025 (USD Billion)
  •  
  • Chapter 11. Company Profile
    • 11.1. Roche
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Product Portfolio
      • 11.1.4. Business Strategy
      • 11.1.5. Recent Developments
    • 11.2. Siemens
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Product Portfolio
      • 11.2.4. Business Strategy
      • 11.2.5. Recent Developments
    • 11.3. Abbott Laboratories
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Product Portfolio
      • 11.3.4. Business Strategy
      • 11.3.5. Recent Developments
    • 11.4. Danaher Corporation
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Product Portfolio
      • 11.4.4. Business Strategy
      • 11.4.5. Recent Developments
    • 11.5. QIAGEN
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Product Portfolio
      • 11.5.4. Business Strategy
      • 11.5.5. Recent Developments
    • 11.6. Thermo Fischer Scientific
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Product Portfolio
      • 11.6.4. Business Strategy
      • 11.6.5. Recent Developments
    • 11.7. Bio-Rad Laboratories
      • 11.7.1. Overview
      • 11.7.2. Financials
      • 11.7.3. Product Portfolio
      • 11.7.4. Business Strategy
      • 11.7.5. Recent Developments
    • 11.8. Agilent Technologies
      • 11.8.1. Overview
      • 11.8.2. Financials
      • 11.8.3. Product Portfolio
      • 11.8.4. Business Strategy
      • 11.8.5. Recent Developments
    • 11.9. Bio-Techne Corporation
      • 11.9.1. Overview
      • 11.9.2. Financials
      • 11.9.3. Product Portfolio
      • 11.9.4. Business Strategy
      • 11.9.5. Recent Developments
    • 11.10. PerkinElmer
      • 11.10.1. Overview
      • 11.10.2. Financials
      • 11.10.3. Product Portfolio
      • 11.10.4. Business Strategy
      • 11.10.5. Recent Developments
    • 11.11. Merck
      • 11.11.1. Overview
      • 11.11.2. Financials
      • 11.11.3. Product Portfolio
      • 11.11.4. Business Strategy
      • 11.11.5. Recent Developments
    • 11.12. bioMerieux
      • 11.12.1. Overview
      • 11.12.2. Financials
      • 11.12.3. Product Portfolio
      • 11.12.4. Business Strategy
      • 11.12.5. Recent Developments

Methodology

Free Analysis

Immunoassay is a type of biochemistry technique that is used either qualitatively or quantitatively to detect the presence of analytes. The analytes present can be in the form of large proteins or antibodies that may be produced due to an infection. This type of test can be used in laboratories or at the site itself. Antibodies or antigens are used as biorecognition agents for detecting the presence of analytes.

According to the National Cancer Institute, in 2018, approximately 1,800,000 new cases of cancer were registered in the U.S. and it caused about 6,00,000 people deaths. This increase in the occurrence of cancer leading to the increased disease diagnosis is likely to drive the immunoassay market in the future. The growing prevalence of other chronic and infectious diseases, such as tuberculosis, AIDS, etc., is projected to further fuel the immunoassay market over the estimated timeframe. The growing awareness about immunoassay techniques for drug and alcohol detection, rising research activities related to immunological disorders and cancer, rapid technological advancements made by major companies, increasing funding by government for the treatment of chronic diseases, and growing biotechnological and pharmaceutical companies in developing countries are also anticipated to boost the global immunoassay market in the years ahead. However, strict regulation for approval of consumables and instruments and unfavorable reimbursement policies may hinder the growth of the immunoassay market globally.

Global Immunoassay Market

The global immunoassay market is divided into product and service, technology, application, platform, and end-user. By product & service, the market for immunoassay is segmented into reagents & kits, software & services, and analyzer. The reagents and kits segment is anticipated to dominate the immunoassay market over the forecast time period, owing to the increasing prevalence of chronic and infectious diseases. By platform, the immunoassay market is segmented into fluorescence immunoassays, radioimmunoassays, enzyme immunoassays, chemiluminescence immunoassays, and others. The enzyme immunoassays segment is anticipated to grow considerably in the global market due to its accurate results related to the detection of various diseases. By technology, the market is segmented into ELISA, ELISPOT, immuno-PCR, rapid tests, western blotting, and others. ELISA dominated the market in 2018, due to its use in the detection of various diseases, such as cancer, infectious disease. The application segment of the market includes oncology, endocrinology, cardiology, infectious diseases, autoimmune disorders, hematology and blood screening, and others. Infectious diseases are expected to dominate the immunoassay market in the upcoming years, owing to the growing prevalence of tuberculosis in developing nations, such as India and China. By end-user, the market is segmented into pharmaceutical and biotechnology companies, clinical laboratories, contract research organization, hospitals, and others. Hospitals are anticipated to dominate the immunoassay market globally.

By region, North America is projected to dominate the global immunoassay market in the upcoming years, owing to rising healthcare expenditure, increasing prevalence of chronic diseases, and growing research activities related to immunological disorders. The Asia Pacific immunoassay market is projected to show the highest rate of growth over the forecast time period, owing to the rising prevalence of infectious diseases in China and India, increasing product launches, growing investments made in R&D by the government, and increased establishments of the pharmaceutical and biotechnological companies.

Some key players of the global immunoassay market are Siemens, Roche, Abbott Laboratories, Danaher Corporation, QIAGEN, Thermo Fischer Scientific, Bio-Rad Laboratories, Agilent Technologies, bioMerieux, Merck, Bio-Techne Corporation, and PerkinElmer.

}